STOCK TITAN

SNDX (NASDAQ: SNDX) holder files to sell 2,082 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SNDX has a Form 144 notice covering a proposed sale of 2,082 shares of its common stock through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of 42,931.05.

The shares were acquired on 02/05/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 02/05/2026. The filing notes that 86,914,838 shares of common stock are outstanding and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SNDX Form 144 filing disclose?

The Form 144 filing for SNDX discloses a planned sale of 2,082 common shares on NASDAQ. The shares were recently acquired through restricted stock vesting and have an aggregate market value of 42,931.05, according to the information provided in the notice.

How many SNDX shares are planned for sale under this Form 144?

The filing covers a planned sale of 2,082 SNDX common shares. These shares are to be sold through Fidelity Brokerage Services LLC on NASDAQ, with the filing listing an aggregate market value of 42,931.05 for the transaction at the time of the notice.

How were the SNDX shares in this Form 144 acquired?

The 2,082 SNDX shares were acquired on 02/05/2026 via a restricted stock vesting transaction from the issuer. The form identifies the nature of payment as compensation, with the date of payment also recorded as 02/05/2026 for these shares.

What is the aggregate market value of SNDX shares to be sold?

The Form 144 lists an aggregate market value of 42,931.05 for the 2,082 SNDX common shares to be sold. This value is based on the market price at the time the notice was prepared and submitted for the planned NASDAQ sale.

How many SNDX shares are outstanding according to the Form 144?

The notice states that 86,914,838 SNDX common shares are outstanding. This figure provides context for the relative size of the proposed 2,082-share sale, as shown in the securities information table within the Form 144 filing.

Which broker and exchange are involved in the SNDX Form 144 sale?

The planned sale of SNDX shares is to be executed through Fidelity Brokerage Services LLC as the broker. The shares are listed for trading on the NASDAQ exchange, according to the securities information section of the Form 144 notice.
Syndax Pharmaceuticals Inc

NASDAQ:SNDX

View SNDX Stock Overview

SNDX Rankings

SNDX Latest News

SNDX Latest SEC Filings

SNDX Stock Data

2.12B
86.32M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK